ADC Therapeutics S.A. Statistics Share Statistics ADC Therapeutics S.A. has 112.5M
shares outstanding. The number of shares has increased by 16.35%
in one year.
Shares Outstanding 112.5M Shares Change (YoY) 16.35% Shares Change (QoQ) 13.43% Owned by Institutions (%) 63.72% Shares Floating 92.48M Failed to Deliver (FTD) Shares 6,700 FTD / Avg. Volume 0.89%
Short Selling Information The latest short interest is 4.07M, so 3.62% of the outstanding
shares have been sold short.
Short Interest 4.07M Short % of Shares Out 3.62% Short % of Float 4.46% Short Ratio (days to cover) 7.18
Valuation Ratios The PE ratio is -1.22 and the forward
PE ratio is -3.03.
ADC Therapeutics S.A.'s PEG ratio is
0.03.
PE Ratio -1.22 Forward PE -3.03 PS Ratio 2.73 Forward PS 5.7 PB Ratio -0.95 P/FCF Ratio -1.55 PEG Ratio 0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ADC Therapeutics S.A..
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.82,
with a Debt / Equity ratio of -0.61.
Current Ratio 3.82 Quick Ratio 3.59 Debt / Equity -0.61 Debt / EBITDA -1.19 Debt / FCF -0.99 Interest Coverage -2.6
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $269.34K Profits Per Employee $-600.17K Employee Count 263 Asset Turnover 0.22 Inventory Turnover 0.32
Taxes Income Tax 166K Effective Tax Rate -0.11%
Stock Price Statistics The stock price has increased by 24.01% in the
last 52 weeks. The beta is 2, so ADC Therapeutics S.A.'s
price volatility has been higher than the market average.
Beta 2 52-Week Price Change 24.01% 50-Day Moving Average 3.24 200-Day Moving Average 2.34 Relative Strength Index (RSI) 70.63 Average Volume (20 Days) 753,769
Income Statement In the last 12 months, ADC Therapeutics S.A. had revenue of 70.84M
and earned -157.85M
in profits. Earnings per share was -1.62.
Revenue 70.84M Gross Profit 64.89M Operating Income -130.65M Net Income -157.85M EBITDA -103.71M EBIT -106.99M Earnings Per Share (EPS) -1.62
Full Income Statement Balance Sheet The company has 250.87M in cash and 123M in
debt, giving a net cash position of 127.87M.
Cash & Cash Equivalents 250.87M Total Debt 123M Net Cash 127.87M Retained Earnings -1.49B Total Assets 321.56M Working Capital 254.16M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -123.83M
and capital expenditures -867K, giving a free cash flow of -124.7M.
Operating Cash Flow -123.83M Capital Expenditures -867K Free Cash Flow -124.7M FCF Per Share -1.28
Full Cash Flow Statement Margins Gross margin is 91.6%, with operating and profit margins of -184.44% and -222.83%.
Gross Margin 91.6% Operating Margin -184.44% Pretax Margin -220.42% Profit Margin -222.83% EBITDA Margin -146.41% EBIT Margin -184.44% FCF Margin -176.04%
